We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$22.7B
AUM Growth
+$6.91B
(+44%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
20.03%
Top 10 Holdings %
Top 10 Hldgs %
42.56%
Holding
3,800
New
1,351
Increased
647
Reduced
509
Closed
1,292
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.95B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$848M |
| 3 |
Applovin
APP
|
+$243M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$142M |
| 5 |
Thomson Reuters
TRI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$443M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$430M |
| 3 |
Shopify
SHOP
|
+$320M |
| 4 |
Flutter Entertainment
FLUT
|
+$240M |
| 5 |
Gilead Sciences
GILD
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.27% |
| 2 | Industrials | 7.89% |
| 3 | Technology | 6.89% |
| 4 | Healthcare | 4.69% |
| 5 | Communication Services | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Energy Vault
NRGV
$633M
| $89K | ﹤0.01% |
125,300
+21,115
| +20% | +$17.1K |
|
2227
Metagenomi Therapeutics
MGX
$46.3M
| $87K | ﹤0.01% |
+59,043
| New | +$92.5K |
|
2228
Beamr Imaging
BMR
$20.2M
| $86K | ﹤0.01% |
+27,270
| New | +$74.4K |
|
2229
InfuSystem Holdings
INFU
$249M
| $86K | ﹤0.01% |
+13,808
| New | +$76.3K |
|
|
DPRO
2230
Draganfly
DPRO
$172M
| $85K | ﹤0.01% |
+26,967
| New | +$62.8K |
|
|
GB
2231
DELISTED
Global Blue Group Holding
GB
| $84K | ﹤0.01% |
+11,317
| New | +$84K |
|
|
BRFS
2232
DELISTED
BRF SA
BRFS
| $83K | ﹤0.01% |
22,939
+11,772
| +105% | +$42.6K |
|
2233
Skye Bioscience
SKYE
$18.3M
| $83K | ﹤0.01% |
+20,036
| New | +$41.5K |
|
2234
BARK
BARK
$101M
| $82K | ﹤0.01% |
+4,690
| New | +$108K |
|
2235
Jasper Therapeutics
JSPR
$23.6M
| $82K | ﹤0.01% |
+14,797
| New | +$72.9K |
|
2236
QuickLogic
QUIK
$257M
| $82K | ﹤0.01% |
+13,391
| New | +$73.6K |
|
|
CONI
2237
GraniteShares 2x Short COIN Daily ETF
CONI
$12.8M
| $82K | ﹤0.01% |
+1,717
| New | +$308K |
|
2238
PUT
AMC Entertainment Holdings
AMC
$2.31B
| $81K | ﹤0.01% |
+26,300
| New | +$78.1K |
|
2239
BlackRock Enhanced International Dividend Trust
BGY
$529M
| $81K | ﹤0.01% |
14,008
-2,372
| -14% | -$13.3K |
|
2240
Innoviz Technologies
INVZ
$112M
| $81K | ﹤0.01% |
+49,643
| New | +$43.4K |
|
2241
MaxCyte
MXCT
$126M
| $81K | ﹤0.01% |
37,497
+20,595
| +122% | +$49.9K |
|
2242
TScan Therapeutics
TCRX
$52M
| $80K | ﹤0.01% |
+55,369
| New | +$80K |
|
|
VXRT
2243
DELISTED
Vaxart
VXRT
| $80K | ﹤0.01% |
+178,883
| New | +$77.8K |
|
|
BRY
2244
DELISTED
Berry Corp
BRY
| $79K | ﹤0.01% |
28,608
-29,717
| -51% | -$79.4K |
|
2245
Corbus Pharmaceuticals
CRBP
$188M
| $79K | ﹤0.01% |
+11,548
| New | +$83.9K |
|
|
QIPT
2246
DELISTED
Quipt Home Medical
QIPT
| $79K | ﹤0.01% |
+44,550
| New | +$87.9K |
|
2247
Atossa Therapeutics
ATOS
$23.5M
| $78K | ﹤0.01% |
+6,340
| New | +$75.8K |
|
2248
GoPro
GPRO
$126M
| $78K | ﹤0.01% |
+103,959
| New | +$67.6K |
|
2249
Lantronix
LTRX
$266M
| $78K | ﹤0.01% |
+27,521
| New | +$62.5K |
|
2250
InnovAge Holding
INNV
$1.52B
| $77K | ﹤0.01% |
21,021
-44,299
| -68% | -$155K |
|
Similar funds
DB
HRT Financial's Q2 2025 Portfolio in Review
As of Q2 2025, HRT Financial held 3,800 positions worth $22.7B, up 44% from $15.8B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
HRT Financial deployed $4.55B of net new capital in Q2 2025, opening 1,351 new positions and adding to 647 existing holdings. Its largest new stake was The AZEK Co: 2,834,659 shares worth $154M.
By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 8.3% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $430M trimmed.
- HRT Financial's largest Q2 2025 buy was The AZEK Co: 2,834,659 shares worth $154M.
- HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $1.95B increase.
- HRT Financial's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $430M.
- HRT Financial fully exited Broadcom in Q2 2025, selling an estimated $443M.
- HRT Financial's ten largest holdings make up 43% of its $22.7B portfolio in Q2 2025.
- HRT Financial opened 1,351 new positions and closed 1,292 in Q2 2025.
- HRT Financial's portfolio value rose 44% quarter-over-quarter to $22.7B.
Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.